Gsk (GSK) Asset Utilization Ratio (2009 - 2026)

Gsk (GSK) has 18 years of Asset Utilization Ratio data on file, last reported at 0.91 in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio rose 41.79% year-over-year to 0.91; the trailing twelve-month figure through Jun 2026 stood at 0.91 (up 41.79% YoY), and the FY2025 full-year result was 0.55, up 2.9% from the prior year.
• Asset Utilization Ratio was 0.91 for Q2 2026 at Gsk, roughly flat from 0.91 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.92 in Q4 2025 to a low of 0.46 in Q3 2022.
• A 5-year average of 0.65 and a median of 0.63 in 2025 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 125.65% in 2022 and declined 3.38% in 2023, its largest moves.
• Gsk's Asset Utilization Ratio stood at 0.62 in 2022, then declined by 3.38% to 0.6 in 2023, then gained by 7.78% to 0.65 in 2024, then jumped by 40.99% to 0.92 in 2025, then retreated by 0.22% to 0.91 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.91 in Q2 2026, 0.91 in Q1 2026, and 0.92 in Q4 2025.